Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Impaired Renal Function and Healthy Subjects”

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01359579
What this trial is testing

The Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

Who this might be right for
Renal Impairment
Anthera Pharmaceuticals 28
Early research (Phase 1)Study completedNCT03302091
What this trial is testing

A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body

Who this might be right for
Renal InsufficiencyHealthy
Boehringer Ingelheim 20
Early research (Phase 1)Study completedNCT02646358
What this trial is testing

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Who this might be right for
Pharmacokinetics of VepoloxamerHealthy VolunteersRenal Impaired
Mast Therapeutics, Inc. 27
Early research (Phase 1)Study completedNCT03680352
What this trial is testing

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

Who this might be right for
PK in Patients With Various Degrees of Renal Impairment
Allecra 30
Early research (Phase 1)Study completedNCT02199379
What this trial is testing

A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects

Who this might be right for
Renal ImpairmentDisease Severity
Eisai Inc. 26
Not applicableWithdrawnNCT01243515
What this trial is testing

Comparison of a Non-Invasive Central Venous Pressure Device and Physical Examination in Patients With Chronic Kidney Disease

Who this might be right for
Central Venous Pressure
Mespere Lifesciences Inc.
Early research (Phase 1)Study completedNCT03087942
What this trial is testing

Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects

Who this might be right for
Renal Insufficiency
Novartis Pharmaceuticals 45
Early research (Phase 1)Study completedNCT01353716
What this trial is testing

Dolutegravir Renal Impairment Study

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 16
Early research (Phase 1)Ended earlyNCT02508740
What this trial is testing

Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment

Who this might be right for
Renal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 31
Early research (Phase 1)Study completedNCT04849650
What this trial is testing

PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment

Who this might be right for
Renal Disease, End Stage
Acacia Pharma Ltd 12
Early research (Phase 1)Study completedNCT06397872
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Madrigal Pharmaceuticals, Inc. 28
Early research (Phase 1)Study completedNCT05505955
What this trial is testing

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Who this might be right for
Glomerulonephritis
Chengdu Suncadia Medicine Co., Ltd. 83
Early research (Phase 1)Study completedNCT02775955
What this trial is testing

PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function

Who this might be right for
Healthy
Pharmaceutical Project Solutions, Inc. 24
Early research (Phase 1)Study completedNCT02634437
What this trial is testing

Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects

Who this might be right for
Renal Function
Allergan 19
Early research (Phase 1)Study completedNCT05954169
What this trial is testing

Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Who this might be right for
Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 16
Early research (Phase 1)Ended earlyNCT04320771
What this trial is testing

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Pharmacology, Clinical
Bayer 18
Early research (Phase 1)Study completedNCT00426036
What this trial is testing

Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine

Who this might be right for
Healthy
Novartis 12
Early research (Phase 1)Study completedNCT04365218
What this trial is testing

Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
AstraZeneca 12
Early research (Phase 1)Study completedNCT01233882
What this trial is testing

Bosutinib In Subjects With Renal Impairment

Who this might be right for
Renal Disease, End-StageRenal Insufficiency, ChronicRenal Insufficiency, Acute
Pfizer 34
Early research (Phase 1)Study completedNCT03605277
What this trial is testing

Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 14
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation